Taking the right forecasting approach for rare diseases
pharmaphorum
NOVEMBER 25, 2022
This is a complex and innovative new treatment, which is highly personalised, as it involves collecting and using the patients’ own immune cells to treat their condition. David James has a long history within global product forecasting and consulting and co-launched J+D in 2005. Case study: CAR-T treatment. About the author.
Let's personalize your content